Fundz

Parse Biosciences Acquires Biomage

PRIVATEJan 16, 2024

Acquiring Company

Parse Biosciences

Acquired Company

Biomage

SeattleGlasgowBiotechnology ResearchSoftware Development

Description

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, has announced its acquisition of data analysis software company Biomage. With this acquisition, customers will have access to a richer suite of single cell data analysis tools through an intuitive interface, empowering researchers with deeper insights and dramatically reduced analysis time.

Quick answer

Parse Biosciences is acquiring Biomage, announced January 16, 2024. Parse Biosciences is based in Seattle, Washington, United States.

How much did Parse Biosciences pay for Biomage?
The deal value was not disclosed.
What does Parse Biosciences do?
Parse Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available.
Where are Parse Biosciences and Biomage based?
Parse Biosciences is based in Seattle, Washington, United States. Biomage is based in Glasgow, Kentucky, United States.
Who are the decision-makers at Parse Biosciences?
Fundz holds 3 contacts at Parse Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Biotechnology Research and Software Development

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Parse Biosciences, and when

When Parse Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Parse Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Parse Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Parse Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Parse Biosciences

Location

Seattle, Washington, United States

About

Parse Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available. With technology founded on the principles of SPLiT-seq, published in Science in 2018, Parse Biosciences' mission is to accelerate progress in scientific research as well as human health. Single-cell sequencing has already enabled groundbreaking discoveries that have led to new understandings in cancer treatment, tissue repair, stem cell therapy, the immune system and much more. At Parse Biosciences we provide researchers with the ability to perform single cell sequencing with unprecedented scale and ease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Parse Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Julie
Likely contact at this company
••••••••@••••••••

See Julie's verified email →

Kaitie
Likely contact at this company
••••••••@••••••••

See Kaitie's verified email →

Alex
Likely contact at this company
••••••••@••••••••

See Alex's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Parse Biosciences's next move

Learn about Strategic plan

Frequently asked

Who acquired Biomage?

Biomage was acquired by Parse Biosciences, based in Seattle. The deal was reported on January 16, 2024. Parse Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available. Parse Biosciences is privately held and operates in Biotechnology Research.

When did Parse Biosciences acquire Biomage?

Parse Biosciences's acquisition of Biomage was reported on January 16, 2024. Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, has announced its acquisition of data analysis software company Biomage. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Biomage do?

Biomage is a data analysis software company that hosts and supports the largest community instance of Cellenics®, a cloud-based single cell RNA sequencing data analysis platform. It is privately held, operating in Software Development, and is based in Glasgow.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.